Holen Sie sich die Stockscreener-App
275.77
0.17%
-0.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CI?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$275.83
Offen:
$279
24-Stunden-Volumen:
260.07K
Relative Volume:
0.16
Marktkapitalisierung:
$72.90B
Einnahmen:
$278.13B
Nettoeinkommen (Verlust:
$6.74B
KGV:
11.68
EPS:
23.6047
Netto-Cashflow:
$7.66B
1W Leistung:
-2.65%
1M Leistung:
-2.53%
6M Leistung:
+2.11%
1J Leistung:
-8.83%
1-Tages-Spanne:
$272.34
$282.45
1-Wochen-Bereich:
$272.34
$286.53
52-Wochen-Spanne:
$239.51
$315.47
Cigna Group Stock (CI) Company Profile
Firmenname
Cigna Group
Sektor
Branche
Telefon
(860) 226-6000
Adresse
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
275.90 | 72.89B | 278.13B | 6.74B | 7.66B | 23.60 |
UNH
Unitedhealth Group Inc
|
384.12 | 359.79B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
94.22 | 122.87B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
396.53 | 87.17B | 201.11B | 4.95B | 6.29B | 22.50 |
HUM
Humana Inc
|
393.37 | 48.40B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-02-06 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-02-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-06-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-22 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-27 | Fortgesetzt | Bernstein | Mkt Perform |
| 2022-05-26 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-02-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-17 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-06 | Bestätigt | BofA Securities | Buy |
| 2021-08-06 | Bestätigt | Citigroup | Buy |
| 2021-08-06 | Bestätigt | Deutsche Bank | Buy |
| 2021-08-06 | Bestätigt | Jefferies | Buy |
| 2021-08-06 | Bestätigt | Mizuho | Buy |
| 2021-08-06 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-06 | Bestätigt | Truist | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-08-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Eingeleitet | UBS | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-24 | Eingeleitet | Edward Jones | Buy |
| 2018-03-13 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-12 | Eingeleitet | Credit Suisse | Outperform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Cigna Group Aktie (CI) Neueste Nachrichten
Evercore ISI initiates Cigna stock with In Line rating on PBM transition risk - Investing.com UK
Cigna Group to hold Investor Day on Sept 30 wit... - Pluang
The Cigna Group to Host Investor Day on September 30 - PR Newswire
Cigna Group stock heads into the open after a 1.09 percent drop. - AD HOC NEWS
Cigna Group stock underperforms Tuesday when compared to competitors - MarketWatch
Cigna (CI) Stock Still Looks Cheap After a 51% Five Year Run - simplywall.st
Internship Spotlight: Shizhou Chen ’27, Cigna - Yale School of Management
(CI) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
After Cigna dropped GLP-1 coverage, employees started a petition - HR Executive
Cigna Group stock heads into the open after the latest Nasdaq close - AD HOC NEWS
Cigna Group stock holds a moderate buy consensus as investors weigh recent earnings - AD HOC NEWS
The Cigna Group (CI) Stock Analysis: Uncovering a Potential 20.85% Upside Amid Robust Growth and Favorable Analyst Ratings - DirectorsTalk Interviews
Price to sales forward of The Cigna Group – NYSE:CI - TradingView
Is Cigna’s Connected Benefits Push Reshaping the Investment Case for Cigna Group (CI)? - simplywall.st
Cigna Group stock holds steady as earnings beat and 2026 guidance support valuation - AD HOC NEWS
Cigna Group (CI) Launches New Benefits Offering Following Questions Over Whether Shares Are Fully Valued - simplywall.st
Cigna Group stock underperforms Friday when compared to competitors - MarketWatch
Cigna Group stock holds steady as investors weigh latest health insurance trends - AD HOC NEWS
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
Cigna Group (NYSE: CI) gives CEO new stock options and restricted shares vesting from 2027 - Stock Titan
Cigna (NYSE: CI) officer schedules Sept sale of vested shares - Stock Titan
Cigna Group Announces New CEO; Wall Street Admits Surprise But Remains Bullish - Stocktwits
The Bull Case For Cigna Group (CI) Could Change Following Its New Connected Benefits Platform Launch - Yahoo Finance
450+ Cigna employees sign petition for change after company stops covering GLP-1s for weight loss - wfsb.com
Director shifts Cigna (NYSE: CI) fees into phantom stock - Stock Titan
If You Invested $100 In Cigna Group Stock 20 Years Ago, You Would Have This Much Today - Benzinga
How Is The Cigna Group’s Stock Performance Compared to Other Healthcare Plans - Barchart.com
Price to sales forward of Cigna Group – BX:CGN - TradingView
Cigna Group stock underperforms Monday when compared to competitors - MarketWatch
Cigna (CI) Stock Still Looks Undervalued On Connected Benefits Launch - simplywall.st
The Cigna Group (CI) Stock Analysis: Exploring a 22.42% Potential Upside and Strong Buy Ratings - DirectorsTalk Interviews
How Investors Are Reacting To Cigna (CI) Linking Medical And Supplemental Benefits For High-Deductible Plans - simplywall.st
Why Cigna Group (CI) Is Back In The Spotlight - Sahm
Can Cigna's Smart Coverage Help Close Health-Cost Gaps? - Yahoo Finance
Piper Sandler Maintains Cigna Group(CI.US) With Buy Rating, Cuts Target Price to $346 - Moomoo
Cigna Healthcare Connects Medical and Supplemental Benefits To Help People Better Manage Unexpected Health Costs - PR Newswire
Cigna Group stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Cigna Group (CI) Could Be 19% Undervalued As AI Spotlight Meets Growth Narrative - Yahoo Finance
Can Cigna Group (CI) Stay Cheap If Earnings Hold Up? - simplywall.st
Cigna Group stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Is Cigna (CI) Using AI Automation And Rebate‑Free Pharmacy To Redefine Its Core Strategy? - simplywall.st
Cigna PAC Spreads $1.17M Across Bipartisan Congress - Legis1
Silvant Capital Management LLC Invests $1.68 Million in Cigna Group $CI - MarketBeat
Mystic Asset Management Inc. Takes Position in Cigna Group $CI - MarketBeat
Tocqueville Asset Management L.P. Makes New $1.31 Million Investment in Cigna Group $CI - MarketBeat
B. Metzler seel. Sohn & Co. AG Takes Position in Cigna Group $CI - MarketBeat
Allworth Financial LP Buys Shares of 32,481 Cigna Group $CI - MarketBeat
Cigna Group (NYSE:CI) Insider Nicole Jones Sells 2,677 Shares - MarketBeat
Cigna Executive Nicole S. Jones Sells 2,677 Shares via Rule 10b5-1 Plan - Kalkine Media
Cigna Group (NYSE: CI) exec logs phantom stock awards - Stock Titan
Cigna Group (NYSE: CI) HR chief sells 2,677 shares under 10b5-1 plan - Stock Titan
Finanzdaten der Cigna Group-Aktie (CI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):